Wafik El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University, shared a post on LinkedIn:

“Pleased to share collaborative manuscript by Jim Abraham et al. colleagues at Caris Life Sciences and the Caris Precision Oncology Alliance. Caris Assure liquid biopsy AI platform evaluates MRD and predicts recurrence.”

Title: Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors

Authors: J. Abraham, V. Domenyuk, N. Perdigones, S. Klimov, S. Antani, T. Yoshino, E. I. Heath, E. Lou, S. V. Liu, J. L. Marshall, W. S. El-Deiry, A. F. Shields, M. F. Dietrich, Y. Nakamura, T. Fujisawa, G. D. Demetri, A. Barker, J. Xiu, D. A. Sacchetti, S. Stahl, R. Hahn-Lowry, A. Stark, J. Swensen, G. Poste, D. D. Halbert, M. Oberley, M. Radovich, G. W. Sledge, David B. Spetzler

You can read the Full Article on Nature.

Wafik El-Deiry: Collaborative Manuscript by Jim Abraham et al. Colleagues at Caris Life Sciences and the Caris Precision Oncology Alliance

More posts featuring Wafik El-Deiry.